Long‐term dopamine receptor blockade not linked to psychotic relapse
A cohort study has found that long‐term use of dopamine D2 receptor antagonists was not associated with increased risk of breakthrough psychosis in patients with first‐episode schizophrenia. Risk of relapse within the cohort decreased over time, the investigators reported. Study results were published online Feb. 19, 2025, in the American Journal of Psychiatry .
Publication Details
- Journal
- The Brown University Psychopharmacology Update
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1002/pu.31308
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00